Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 20 August 2027
- Last conf. stmt
- 6 August 2026
Reach Separations Limited
- Incorporated
- 15 November 2011 (14 years)
- Industry
- Other professional, scientific and technical activities n.e.c. (74909)
- Directors
- Ross Thomas Burn
- Owned by
- Accounts type
- Audit exemption subsidiary
- Region
- East Midlands
- Address
- Biocity NottinghamPennyfoot StreetNottinghamNG1 1GF
Charges
- Total
- 3
- Outstanding
- 1
- Part satisfied
- 0
- Satisfied
- 2
Officers 5 active
Officer details are public data from the Companies House register.
Director · Appointed 6 June 2024
British
Born June 1983 (43)
Burn, Ross Thomas
Director · Appointed 6 June 2024
British
Born February 1981 (45)
Director · Appointed 6 June 2024
Also at Capital Drug Development Ltd
British
Born August 1973 (53)
Director · Appointed 15 November 2011
British
Born July 1962 (64)
Ridgway, Peter Fredrick
Director · Appointed 15 November 2011
British
Born July 1972 (54)
Officer history (2 former)
27 March 2026
Resigned Abbott, Phillip Andrew as Director
31 July 2025
Resigned Theobald, Jerome Yves Martin as Director
6 June 2024
6 June 2024
Appointed Burn, Ross Thomas as Director
6 June 2024
6 June 2024
Appointed Theobald, Jerome Yves Martin as Director
17 February 2012
Appointed Abbott, Phillip Andrew as Director
15 November 2011
15 November 2011
Appointed Ridgway, Peter Fredrick as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 6 June 2024
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Limited Company
Reg. no. 14128337
Former controllers (6)
6 June 2024
6 June 2024
Ceased Peter Fredrick Ridgway — Owns 25–50% of shares
6 June 2024
Ceased Phillip Andrew Abbott — Owns 25–50% of shares
22 January 2018
Ceased Peter Fredrick Ridgway — Owns 25–50% of shares
22 January 2018
22 January 2018
Ceased Phillip Andrew Abbott — Owns 25–50% of shares
Group structure 5 shown
Ownership group derived from the Companies House PSC register
Catsci Group Holdings Limited Owns 75–100% of shares
Catsci Holdings Ltd Owns 75–100% of shares
Capital Drug Development Ltd Owns 75–100% of shares
Reach Separations Limited This company Owns 75–100% of shares
Financials
Figures from 2023 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £450,624
- Cash
- £314,324
- Profit
- £280,589
- Employees
- 19
- Debt Ratio
- 73%
- Current Ratio
- 2.1x
- Return on Equity
- 62%
Trend
Net Assets
Balance sheet detail
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Fixed Assets | £716,250 | £750,471 | £434,028 | £241,112 |
| Current Assets | £940,637 | £979,021 | £810,479 | £418,722 |
| Cash | £314,324 | £457,187 | £519,361 | £114,368 |
| Creditors (< 1 year) | £453,356 | £401,950 | £312,992 | £262,023 |
| Creditors (> 1 year) | £606,999 | £572,518 | £405,432 | £55,052 |
| Net Current Assets | £487,281 | £577,071 | £497,487 | £156,699 |
| Net Assets | £450,624 | £636,835 | £466,834 | £319,308 |
| Shareholder Funds | £450,624 | £636,835 | £466,834 | £319,308 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 9 August 2026 | Confirmation statement with no updates | 6 August 2026 | ||
| 15 April 2026 | Satisfaction of a charge in full | |||
| 27 March 2026 | Termination of appointment of a director | |||
| 17 February 2026 | Registration of a charge | |||
| 12 November 2025 | Satisfaction of a charge in full |
Some other companies at this address
Other companies in this industry
Salford
London
Ross-On-Wye
London
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →